UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
                            
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2(a)
Under the Securities Exchange Act of 1934
(Amendment No. *)
Anaplan, Inc.
(Name of Issuer)
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
03272L108
(CUSIP Number)

Michael D. Adamski
Sachem Head Capital Management LP
250 West 55th Street, 34th Floor
New York, New York 10019
(212) 714-3300
With a copy to:
Richard M. Brand
Cadwalader, Wickersham & Taft LLP
200 Liberty Street
New York, NY 10281
212-504-6000
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
March 7, 2022
(Date of Event Which Requires Filing of This Statement)
                            
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box. ☐ 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

 *
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).


 
CUSIP No. 03272L108
 
Page 2

 
1
 
NAME OF REPORTING PERSON

Sachem Head Capital Management LP
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☒ (b) ☐
 
3
 
SEC USE ONLY
 

4
 
SOURCE OF FUNDS
 
OO (See Item 3)
5
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ☐

 
6
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
Number of
shares
beneficially
owned by
each
reporting
person
with
 
 
7
 
SOLE VOTING POWER
 
0
 
8
 
SHARED VOTING POWER
 
7,316,900
 
9
 
SOLE DISPOSITIVE POWER
 
0
 
10
 
SHARED DISPOSITIVE POWER

7,316,900
11
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
7,316,900
12
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ☐
 

13
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
4.95%*
14
 
TYPE OF REPORTING PERSON
 
IA
* All percentage calculations set forth herein are based upon the aggregate of 147,661,622 shares of Common Stock outstanding as of November 26, 2021, as reported in Anaplan’s Form 10-Q filed with the Securities and Exchange Commission (the “SEC”) on December 2, 2021.


 
CUSIP No. 03272L108
 
Page 3


1
 
NAME OF REPORTING PERSON

Uncas GP LLC
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☒ (b) ☐
 
3
 
SEC USE ONLY
 

4
 
SOURCE OF FUNDS
 
OO (See Item 3)
5
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ☐
 

6
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
Number of
shares
beneficially
owned by
each
reporting
person
with
 
 
7
 
SOLE VOTING POWER
 
0
 
8
 
SHARED VOTING POWER
 
7,316,900
 
9
 
SOLE DISPOSITIVE POWER
 
0
 
10
 
SHARED DISPOSITIVE POWER

7,316,900
11
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
7,316,900
12
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ☐
 

13
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
4.95%*
14
 
TYPE OF REPORTING PERSON
 
OO
* All percentage calculations set forth herein are based upon the aggregate of 147,661,622 shares of Common Stock outstanding as of November 26, 2021, as reported in Anaplan’s Form 10-Q filed with the SEC on December 2, 2021


 
CUSIP No. 03272L108
 
Page 4


1
 
NAME OF REPORTING PERSON

Sachem Head GP LLC
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☒ (b) ☐
 
3
 
SEC USE ONLY
 

4
 
SOURCE OF FUNDS
 
OO (See Item 3)
5
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ☐
 

6
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
Delaware
Number of
shares
beneficially
owned by
each
reporting
person
with
 
 
7
 
SOLE VOTING POWER
 
0
 
8
 
SHARED VOTING POWER
 
5,390,200
 
9
 
SOLE DISPOSITIVE POWER
 
0
 
10
 
SHARED DISPOSITIVE POWER

5,390,200
11
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
5,390,200
12
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ☐
 

13
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
3.65%*
14
 
TYPE OF REPORTING PERSON
 
OO
* All percentage calculations set forth herein are based upon the aggregate of 147,661,622 shares of Common Stock outstanding as of November 26, 2021, as reported in Anaplan’s Form 10-Q filed with the SEC on December 2, 2021.


 
CUSIP No. 03272L108
 
Page 5


1
 
NAME OF REPORTING PERSON

Scott D. Ferguson
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☒ (b) ☐
 
3
 
SEC USE ONLY
 

4
 
SOURCE OF FUNDS
 
OO (See Item 3)
5
 
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) ☐
 

6
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
Number of
shares
beneficially
owned by
each
reporting
person
with
 
 
7
 
SOLE VOTING POWER
 
0
 
8
 
SHARED VOTING POWER
 
7,316,900
 
9
 
SOLE DISPOSITIVE POWER
 
0
 
10
 
SHARED DISPOSITIVE POWER

7,316,900
11
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
7,316,900
12
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ☐
 

13
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
 
4.95%*
14
 
TYPE OF REPORTING PERSON
 
IN
* All percentage calculations set forth herein are based upon the aggregate of 147,661,622 shares of Common Stock outstanding as of November 26,2021, as reported in Anaplan’s Form 10-Q filed with the SEC on December 2, 2021.


 
CUSIP No. 03272L108
 
Page 6


ITEM 1.
SECURITY AND ISSUER
This statement on Schedule 13D (“Schedule 13D”) relates to the common stock, par value $0.0001 per share (the “Common Stock”), of Anaplan, Inc., a Delaware corporation (the “Issuer”). The principal executive offices of the Issuer are located at 50 Hawthorne Street, San Francisco, California 94105.
 
ITEM 2.
IDENTITY AND BACKGROUND
(a), (f) This statement is being filed by:

(i)           Sachem Head Capital Management LP, a Delaware limited partnership (“Sachem Head”);

(ii)          Uncas GP LLC, a Delaware limited liability company (“SH Management”);

(iii)         Sachem Head GP LLC, a Delaware limited liability company (“Sachem Head GP”); and

(iv)         Scott D. Ferguson, a citizen of the United States of America (together with Sachem Head, SH Management and Sachem Head GP, the “Reporting Persons”).
The Reporting Persons have entered into a joint filing agreement, dated as of March 17, 2022, a copy of which is attached hereto as Exhibit 99.1.
(b) The address of the principal business and principal office of each of the Reporting Persons is 250 West 55th St., Floor 34, New York, New York 10019.
(c) Sachem Head’s principal business is to serve as investment advisor to certain funds, including Sachem Head LP, a Delaware limited partnership (“SH”), SH Sagamore Master IX Ltd., an exempted company organized under the laws of the Cayman Islands (“Sagamore Master IX”), Sachem Head Master LP, an exempted limited partnership organized under the laws of the Cayman Islands (“SHM”), SH Stony Creek Master Ltd., an exempted company incorporated under the laws of the Cayman Islands (“Stony Creek”), and SH Old Quarry Master Ltd., an exempted company incorporated under the laws of the Cayman Islands  (“Old Quarry Master”, and together with SH, Sagamore Master IX, SHM, and Stony Creek, the “Sachem Head Funds”).
SH Management’s principal business is to serve as the sole general partner of Sachem Head Capital Management LP.
Sachem Head GP’s principal business is to serve as the general partner of certain affiliated funds, including SH and SHM.
Mr. Ferguson’s principal occupation is to serve as the managing partner of Sachem Head and the managing member of SH Management and Sachem Head GP.
(d), (e) During the last five years, none of the Reporting Persons (i) has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) was a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violations with respect to such laws.

ITEM 3.
SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
The responses to Item 4, 5 and 6 of this Schedule 13D are incorporated herein by reference.
The net investment costs (including commissions, if any) of the Common Stock, the Cash Settled Swaps (as defined below) and the Physically Settled Swaps (as defined below) referenced in Items 5 and 6 directly owned by the Sachem Head Funds is approximately $606,963,877. The source of funding for such transactions was derived from the respective capital of the Sachem Head Funds.




 
CUSIP No. 03272L108
 
Page 7


ITEM 4.
PURPOSE OF TRANSACTION
The responses to Item 3, 5 and 6 of this Schedule 13D are incorporated herein by reference.
The Reporting Persons believe that the Issuer’s Common Stock is undervalued and is an attractive investment. 
The Reporting Persons intend to engage in discussions with the Issuer and the Issuer’s management and board of directors, other stockholders of the Issuer and other interested parties on issues that may relate to the business, management, operations, assets, capitalization, financial condition, strategic plans, governance and board composition and the future of the Issuer.
On February 28, 2022, Sagamore Master IX, in compliance with the Amended and Restated Bylaws of the Issuer (the “Bylaws”), submitted to the Issuer its formal notice of intent (the “Notice”) to present certain stockholder proposals and nominate candidates for election to the board of directors of the Issuer (the “Board”), in each case, at the 2022 annual meeting of stockholders of the Issuer (including any adjournment or postponement thereof or any special meeting held in lieu thereof, the “2022 Annual Meeting”).
The Notice stated that, at the 2022 Annual Meeting, Sagamore Master IX, in its capacity as a stockholder of record of the Issuer, intends to nominate for election as directors of the Issuer, Richard M. Haddrill, Roger S. Siboni and Andrew J. Stafman (each a “Nominee” and, collectively, the “Nominees”).
In the Notice, the Reporting Persons reserved the right to further nominate, substitute or add additional persons in the event that (a) the Issuer purports to increase the number of directorships, (b) the Issuer makes or announces any changes to the Bylaws or takes or announces any other action that would have the effect of disqualifying any of the Nominees and/or (c) any Nominee is unable or hereafter becomes unwilling for any reason to serve as a director.
Sagamore Master IX also submitted to the Issuer stockholder proposals for consideration at the 2022 Annual Meeting, proposing (i) the repeal of each provision of, or amendment to, the Bylaws adopted by the Board without the approval of the stockholders of the Issuer subsequent to March 29, 2019, which is the date of the most recent publicly available amendment to the Bylaws (the “Bylaw Proposal”) and (ii) that the Board take all action necessary to adopt an amendment to the Issuer’s Amended and Restated Certificate of Incorporation (as amended or restated and in effect as of the date hereof, the “Charter”) and Bylaws of the Issuer to fully eliminate the classified structure of the Board, in a manner such that the term of each member of the Board shall expire at the Issuer's annual stockholder meeting for 2023 (the “2023 Annual Meeting”) and any director elected to the Board at or after the 2023 Annual Meeting shall be elected on an annual basis (the “Board Declassification Proposal” and, together with the Bylaw Proposal, the “Stockholder Proposals”).
Sachem Head, on behalf of Sagamore Master IX, has entered into an engagement and indemnification agreement (the “Engagement and Indemnification Agreement”) with Mr. Haddrill and Mr. Siboni, substantially in the form set forth as Exhibit 99.2 hereto, pursuant to which, Mr. Haddrill and Mr. Siboni each agreed to be named as a nominee in Sachem Head’s proxy soliciting materials related to the 2022 Annual Meeting and to serve as a director if elected. Sachem Head has also agreed to indemnify each Nominee against any losses suffered, incurred or sustained by such Nominee in connection with certain indemnifiable events and reimburse each Nominee for reasonable out-of-pocket travel expenses incurred as a result of such Nominee being a member of the slate and expenses in connection with legal counsel retained to represent such Nominee. Each Nominee each received $100,000 upon execution of the Engagement and Indemnification Agreement. The foregoing is qualified in its entirety by reference to Exhibit 99.2, which is incorporated herein by reference.
The Reporting Persons may also take one or more of the actions described in subsections (a) through (j) of Item 4 of Schedule 13D, and may discuss such actions with the Issuer and the Board and management team, stockholders and other persons. The Reporting Persons currently intend to conduct a proxy solicitation to elect the Nominees and approve the Stockholder Proposals at the 2022 Annual Meeting.
The Reporting Persons intend to review their investments in the Issuer on a continuing basis. Depending on various factors, including, without limitation, the outcome of any discussions referenced above, the Issuer’s financial position and strategic direction, actions taken by the Board, price levels of the Common Stock, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may from time to time and at any time in the future take such actions with respect to the investment in the Issuer as they deem appropriate, including, without limitation, purchasing additional shares of Common Stock or other financial instruments that are based upon or relate to the value of the Common Stock, selling or obtaining financing on some or all of their beneficial or economic holdings, engaging in hedging or similar


 
CUSIP No. 03272L108
 
Page 8

transactions with respect to securities that are based upon or relate to the value of the Common Stock and/or otherwise changing their intentions with respect to any and all matters referred to in Item 4 of Schedule 13D.

ITEM 5.
INTEREST IN SECURITIES OF THE ISSUER
(a), (b) Sachem Head, SH Management and Mr. Ferguson may be deemed to beneficially own 7,316,900 shares of Common Stock (the “Subject Shares”), including 1,033,239 shares of Common Stock underlying Physically Settled Swaps (as defined below) that Sachem Head, SH Management, and Mr. Ferguson may be deemed to beneficially own upon satisfaction of certain conditions. The Subject Shares collectively represent approximately 4.95% of the outstanding shares of Common Stock, based on 147,661,622 shares of Common Stock outstanding as of November 26, 2021, as reported in the Issuer’s Quarterly Report on Form 10-Q filed on December 2, 2021.
Sachem Head, as the investment adviser to the Sachem Head Funds, may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) all of the Subject Shares. As the general partner of Sachem Head, SH Management may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) all of the Subject Shares. As the general partner of SH and SHM, Sachem Head GP may be deemed to have the shared power to vote or to direct the vote of (and the shared power to dispose or direct the disposition of) 5,390,200 of the Subject Shares, including 1,033,239 shares of Common Stock that Sachem Head GP may be deemed to beneficially own upon satisfaction of certain conditions, constituting 3.65% of the outstanding shares of Common Stock. By virtue of Mr. Ferguson’s position as the managing partner of Sachem Head and the managing member of SH Management and Sachem Head GP, Mr. Ferguson may be deemed to have the shared power to vote or direct the vote of (and the shared power to dispose or direct the disposition of) all of the Subject Shares.
On March 7, 2022, Mr. Keith Meister, the managing partner of Corvex Management LP (“Corvex”), and Mr. Ferguson orally agreed to coordinate and cooperate in certain of their activities with regard to the Issuer. Sachem Head and Corvex thereafter negotiated, and on March 15, 2022 entered into, the Advocacy Agreement described in Item 6 and attached as Exhibit 99.3, which, among other things, provides that the parties thereto will coordinate and cooperate with one another in certain activities related to the Issuer, including, without limitation, in communications with the Issuer and other stockholders, regulatory filings and the conduct of any proxy contest. By virtue of the agreements and arrangements between Corvex and Sachem Head, including the Advocacy Agreement and the obligations and rights thereunder, the Reporting Persons are part of a “group” (within the meaning of Section 13(d)(3) of the Act) comprised of the Reporting Persons and Corvex (the “Group”).
Each member of the Group will file a separate Schedule 13D (or Schedule 13D amendment) under the Act containing its required information, including reporting the interests in Common Stock that each member of the Group may be deemed to beneficially own. No member of the Group assumes any responsibility for the information contained in the Schedule 13D or Schedule 13D amendment filed by the other member of the Group.  Based in part on information provided by or behalf of the Group members, the Reporting Persons and the Group may be deemed to beneficially own in the aggregate 11,240,296 shares of Common Stock, representing 7.6% of the outstanding shares of Common Stock. The Reporting Persons expressly disclaim beneficial ownership over any Common Stock that they may be deemed to beneficially own solely by reason of the agreements and arrangements between Corvex and Sachem Head, including the Advocacy Agreement, and beneficial ownership of any securities of the Issuer other than those reported in this Schedule 13D.
(c)  Exhibit 99.4 filed herewith, which is incorporated herein by reference, describes the transactions in the Common Stock that were effected by the Reporting Persons for the benefit of the Sachem Head Funds during the past sixty days.
(d) The Sachem Head Funds have the right to receive dividends from, and the proceeds from the sale of, the Subject Shares.
(e) Not applicable.
 
ITEM 6.
CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER
The responses to Item 3, 4 and 5 of this Schedule 13D are incorporated herein by reference.
On March 7, 2022, Mr. Keith Meister and Mr. Ferguson orally agreed to coordinate and cooperate in their activities with regard to the Issuer. Sachem Head and Corvex thereafter entered into an Advocacy Agreement (the “Advocacy Agreement”), dated as of March 15, 2022, a copy of which is attached hereto as Exhibit 99.3 and incorporated herein by reference. Pursuant to the Advocacy Agreement, each of Sachem Head and Corvex have agreed that, among others things, the parties shall use their reasonable best efforts to consult with each other in connection with the following matters: (i) the manner, form, content and timing of any communications with the Issuer or any of its other stockholders, including (a) the selection of


 
CUSIP No. 03272L108
 
Page 9

nominees to serve as directors of the Issuer, (b) making, revising, or withdrawing any proposals to other stockholders of the Issuer or to the Issuer, and (c) the conduct of any proxy contest, consent solicitation or similar actions in respect of the Issuer; (ii) the manner, form, content and timing of any regulatory or public disclosures, public statements or other communications relating to the Issuer, the Company Securities (as defined in the Advocacy Agreement), and the Advocacy Agreement, (iii) admission of any additional members to the Group, and (iv) entering into any confidentiality, extension, settlement, cooperation, standstill or other similar agreement with the Issuer. The parties retain full discretion with respect to voting of their respective Company Securities. References to, and descriptions of, the Advocacy Agreement set forth herein are not intended to be complete and are qualified in their entirety by reference to the text of the Advocacy Agreement.
The Sachem Head Funds have entered into physically settled swaps (the “Physically Settled Swaps”) referencing 1,033,239 shares of Common Stock in the aggregate that the Reporting Persons may be deemed to beneficially own. Under the terms of each Physically Settled Swap, upon settlement, (i) a Sachem Head Fund will be obligated to pay to the counterparty the specified price for the specified notional number of shares, plus interest at the rate set forth in the applicable contract and (ii) the counterparty will be obligated to deliver to the respective Sachem Head Fund the specified notional number of shares and to pay to the respective Sachem Head Fund an amount equal to dividends paid on the specified notional number of shares. The counterparties to the Physically Settled Swaps are unaffiliated third party financial institutions.
The Sachem Head Funds have entered into cash-settled total return swaps (the “Cash Settled Swaps”) referencing 6,310,744 shares of Common Stock.  Under the terms of each Cash Settled Swap, upon settlement, (i) Sagamore Master IX or Old Quarry Master will be obligated to pay to the counterparty any negative price performance of the specified notional number of shares subject to the Cash Settled Swaps, plus interest rates set forth in the applicable contracts, and (ii) the counterparty will be obligated to pay Sagamore Master IX or Old Quarry Master any positive price performance of the specified notional number of shares subject to the Cash Settled Swaps. Any dividends received by the counterparty on such notional shares during the term of the Cash Settled Swaps will be paid to Sagamore Master IX or Old Quarry Master. All balances will be settled in cash. The counterparties to the Cash Settled Swaps are unaffiliated third party financial institutions. The Cash Settled Swaps do not give any Reporting Person direct or indirect voting, investment or dispositive control over any securities of the Issuer and do not require the counterparty thereto to acquire, hold, vote or dispose of any securities of the Issuer. Accordingly, the Reporting Persons disclaim any beneficial ownership of any shares of Common Stock that may be referenced in the Cash Settled Swap contracts or shares of other securities or financial instruments that may be held from time to time by any counterparty to the contracts.
The Sachem Head Funds may, from time to time, enter into and dispose of swaps, options or other derivative transactions with one or more counterparties that are based upon the value of shares of the Common Stock, which transactions may be significant in amount. The profit, loss and/or return on such contracts may be wholly or partially dependent on the market value of the shares of the Common Stock.
Except as described herein, the Reporting Persons have no contracts, arrangements, understandings or relationships (legal or otherwise) with respect to any securities of the Issuer.
 
ITEM 7.
MATERIAL TO BE FILED AS AN EXHIBIT
   
Joint Filing Agreement among Sachem Head Capital Management LP, Uncas GP LLC, Sachem Head GP LLC and Scott D. Ferguson
 
Form of Engagement and Indemnification Agreement entered into by and between Sachem Head Capital Management LP on behalf of SH Sagamore Master IX Ltd, Richard M. Haddrill and Roger S. Siboni
 
 
Advocacy Agreement among Sachem Head Capital Management LP and Corvex Management LP
 
Trading Data
   



 
CUSIP No. 03272L108
 
Page 10


SIGNATURES
After reasonable inquiry and to the best of each of the undersigned’s knowledge and belief, each of the undersigned certify that the information set forth in this statement is true, complete and correct.
 
Date: March 17, 2022

 
SACHEM HEAD CAPITAL MANAGEMENT LP
 
     
       
 
By:
Uncas GP LLC, its General Partner
 
       
       
 
By:
/s/ Scott D. Ferguson  
    Name:  Scott D. Ferguson  
    Title:     Managing Member  
       

 
UNCAS GP LLC
 
       
       
 
By:
/s/ Scott D. Ferguson  
    Name:  Scott D. Ferguson  
    Title:     Managing Member  
       

 
SACHEM HEAD GP LLC
 
       
       
 
By:
/s/ Scott D. Ferguson  
    Name:  Scott D. Ferguson  
    Title:     Managing Member  
       

 
SCOTT D. FERGUSON
 
       
       
 
By:
/s/ Scott D. Ferguson  
    Name:  Scott D. Ferguson  
       







 
INDEX TO EXHIBITS
 
Exhibit
 
Description
Joint Filing Agreement among Sachem Head Capital Management LP, Uncas GP LLC, Sachem Head GP LLC and Scott D. Ferguson
 
Form of Engagement and Indemnification Agreement entered into by and between Sachem Head Capital Management LP on behalf of SH Sagamore Master IX Ltd, Richard M. Haddrill and Roger S. Siboni
 
 
Advocacy Agreement among Sachem Head Capital Management LP and Corvex Management LP
 
Trading Data

















Exhibit 99.1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, each of the undersigned hereby agrees to the joint filing, along with all other such undersigned, on behalf of the Reporting Persons (as defined in the joint filing), of a statement on Schedule 13D (including amendments thereto) with respect to the common stock, par value $0.0001 per share, of Anaplan, Inc., and that this agreement be included as an Exhibit 99.1 to such joint filing. This agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument. The undersigned acknowledge that each shall be responsible for the timely filing of any amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others.

IN WITNESS WHEREOF, each of the undersigned hereby executes this agreement as of this 17 day of March, 2022.

 
SACHEM HEAD CAPITAL MANAGEMENT LP
 
     
       
 
By:
Uncas GP LLC, its General Partner
 
       
       
 
By:
/s/ Scott D. Ferguson  
    Name:  Scott D. Ferguson  
    Title:     Managing Member  
       

 
UNCAS GP LLC
 
       
       
 
By:
/s/ Scott D. Ferguson  
    Name:  Scott D. Ferguson  
    Title:     Managing Member  
       

 
SACHEM HEAD GP LLC
 
       
       
 
By:
/s/ Scott D. Ferguson  
    Name:  Scott D. Ferguson  
    Title:     Managing Member  
       

 
SCOTT D. FERGUSON
 
       
       
 
By:
/s/ Scott D. Ferguson  
    Name:  Scott D. Ferguson  
       




Exhibit 99.2


ENGAGEMENT AND INDEMNIFICATION AGREEMENT, dated as of [•], 2022 (this “Agreement”), by and between Sachem Head Capital Management LP (“Sachem Head”) and [•] (“Nominee”).
WHEREAS, Sachem Head has asked Nominee, and Nominee has agreed, to be (i) a member of the slate of nominees (the “Slate”) of Sachem Head or an affiliate thereof for election to the Board of Directors (the “Board of Directors”) of Anaplan, Inc., a Delaware corporation (the “Company”), at the 2022 annual meeting of stockholders of the Company (including any adjournments or postponements thereof) (the “Annual Meeting”) and/or at any special meeting of the stockholders of the Company (including any adjournments or postponements thereof) (a “Special Meeting”) and (ii) named as such in the proxy solicitation materials related to the Annual Meeting and/or a Special Meeting;
WHEREAS, Sachem Head may solicit proxies from the stockholders of the Company in support of Nominee’s election as a director of the Company at the Annual Meeting and/or a Special Meeting (the “Solicitation”); and
WHEREAS, Nominee has agreed to serve as a director of the Company if so elected at the Annual Meeting and/or a Special Meeting or appointed by other means.
NOW, THEREFORE, in consideration of the foregoing and with the understanding on the part of Sachem Head that Nominee is relying on this Agreement in agreeing to be a nominee as aforesaid and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:
1. Certain Definitions. As used in this Agreement, the following  terms shall have the meanings indicated below:
Claim” means any threatened, pending or completed action, suit or proceeding (whether civil, criminal, administrative, formal or informal, investigative or other), whether instituted by Sachem Head, the Company or any other party, or any inquiry or investigation that Nominee in good faith believes might lead to the institution of any such action, suit or proceeding.
Expenses” means all reasonable out-of-pocket attorneys’ fees and all other reasonable out-of-pocket fees, costs, and expenses paid or incurred in connection with the Solicitation or related matters, as applicable, including without limitation, investigating, defending or participating in (as a party, witness or otherwise, including on appeal), or preparing to defend or participate in, any Claim relating to any Indemnifiable Event, including the reasonable out-of-pocket costs and expenses of Nominee incurred in connection with seeking enforcement of this Agreement in the event that Nominee is successful in such enforcement action, in each case except to the extent arising out of or resulting from Nominee’s willful violation of state or federal law in connection with the Solicitation, gross negligence, willful misconduct, bad faith or a material misstatement or omission in any information provided by Nominee in connection with the Solicitation, and in each case to the extent not otherwise covered by insurance or indemnification from another source (including, without limitation, the Company).
Indemnifiable Event” means any event or occurrence arising out of, or any action taken or omitted to be taken in connection with, the Solicitation or being a member of the

Slate, in each case except to the extent arising out of or resulting from Nominee’s willful violation of state or federal law in connection with the Solicitation, gross negligence, willful misconduct, bad faith or a material misstatement or omission in the information provided by the Nominee in connection with the Solicitation and in each case to the extent not otherwise covered by insurance or indemnification from another source (including, without limitation, the Company).
Loss or Losses” means any and all damages, judgments, fines, penalties, amounts paid or payable in settlement, deficiencies, losses and Expenses (including all interest, assessments, and other charges paid or payable in connection with or in respect  of  such  Losses), in each case except to the extent arising out of or resulting from Nominee’s willful violation of state or federal law in connection with the Solicitation, gross negligence, willful misconduct, bad faith or a material misstatement or omission in the information provided by the Nominee in connection with the Solicitation, and in each case to the extent not otherwise covered by insurance or indemnification from another source (including, without limitation, the Company).
2. Agreement to be Named and Serve; Consideration. Nominee hereby agrees to (a) be a nominee for election to the Board of Directors of the Company at the Annual Meeting and/or a Special Meeting, (b) be named as such in the proxy solicitation materials related to the Annual Meeting and/or a Special Meeting, (c) serve as a director of the Company if so elected at the Annual Meeting and/or a Special Meeting or appointed by other means, (d) devote the time and energy necessary to participate in the Solicitation as requested by Sachem Head, subject to reasonable attempts to accommodate Nominee’s other professional responsibilities and avoid conflicts with Nominee’s pre-existing schedule, by Nominee making him or herself available to attend and participate in meetings with, interviews with and presentations to stockholders, analysts, fund managers, representatives of nominee holders, proxy advisory firms, members of the media, and other persons Sachem Head may reasonably request in connection with the Solicitation, the election of the Slate or any stockholder resolutions Sachem Head may determine to bring before the Company’s stockholders in connection with the Solicitation and (e) subject to Section 4 below, reasonably cooperate with Sachem Head in connection with any litigation or investigation arising out of or related to the Solicitation, including the nomination of the Slate, and subject to reasonable attempts to accommodate Nominee’s other professional responsibilities and avoid conflicts with Nominee’s pre-existing schedule, to be reasonably available to respond to and participate as reasonably necessary in any such action or investigation. Sachem Head will pay Nominee $100,000 upon mutual execution of this Agreement (the “Nominee Payment”), provided that Nominee agrees to promptly repay the Nominee Payment to Sachem Head if (i) the results of the background and reference check referred to in Section 3 hereof is unsatisfactory to Sachem Head in its sole discretion, or (ii) Nominee withdraws from the Slate for any reason prior to the termination of this Agreement. Except as set forth herein, the parties hereto agree that Nominee shall not be entitled to receive any cash or other consideration from Sachem Head in respect of Nominee’s agreements contained herein, whether or not Nominee is elected to the Board of Directors of the Company.
3. Questionnaires; Disclosure of Information. Nominee hereby agrees (a) to promptly complete and sign one or more questionnaires requesting information relating to Nominee’s background and qualifications (the “Questionnaires”) and any written consents that


are required to be completed and delivered to the Company in order to be eligible to be a nominee for election to the Board of Directors and to serve as a director if elected (the “Written Consent”), (b) that Nominee’s responses in the Questionnaires and the representations made in the Written Consent will be true, complete and correct in all material respects and will not omit any material information, (c) that Nominee will provide true, correct and complete information concerning such other matters as are required or customary to be disclosed regarding Nominee, his or her nomination to the Board of Directors or the Solicitation under (i) the Company’s bylaws or (ii) pursuant to the rules and regulations contained in the Securities Exchange Act of 1934, as amended, or the rules and regulations promulgated thereunder, (d) that Nominee will promptly provide any additional information as may be requested by Sachem Head, such information to be true and correct and not omit any material information, and (e) that Nominee will promptly notify Sachem Head of any changes or updates to any information provided by Nominee to Sachem Head pursuant to this Section 3. Nominee further agrees that Sachem Head may forward the Written Consent and the Questionnaires to the Company, and both Sachem Head and the Company may at any time, in their respective discretion, publicly disclose such information, as well as the existence and contents of this Agreement. Furthermore, Nominee understands that Sachem Head may elect, at its expense, to conduct a background and reference check of Nominee and Nominee agrees to complete and execute any necessary authorization forms or other documents required in connection therewith.
   4.              Indemnification.
(a) In the event Nominee was, is or becomes a party to or other participant in, or is threatened to be made a party to or other participant in, a Claim by reason of (or arising or allegedly arising in any manner out of or relating to in whole or in part) an Indemnifiable Event, Sachem Head or a designee thereof, to the fullest extent permitted by applicable law, shall indemnify and hold harmless Nominee from and against any and all Losses suffered, incurred or sustained by Nominee or to which Nominee becomes subject, arising out of such Claim (it being understood and agreed that, except as provided in Section 4(c) with respect to Expenses, reimbursements of any such Losses payable hereunder shall be made as soon as practicable but in any event no later than 30 days after written request is made to Sachem Head accompanied by supporting documentation).
Nominee shall give Sachem Head prompt written notice of any Claim (accompanied by such reasonable supporting documentation as may be in Nominee’s possession) as soon as Nominee becomes aware thereof.
(b) In the case of the commencement of any Claim against Nominee in respect of which he or she may seek indemnification from Sachem Head hereunder, Sachem Head will be entitled to participate therein, including, without limitation, the negotiation and approval of any settlement of such Claim. In addition, Sachem Head  shall have the right to assume control of the defense of such Claim with counsel chosen by Sachem Head. To the extent that Sachem Head may wish to assume the defense of  any Claim against Nominee in respect of which Nominee may seek indemnification from Sachem Head hereunder, Sachem Head shall provide Nominee with written notice of Sachem Head’s election to assume the defense of such Claim. From and after such election by Sachem Head to assume defense of a Claim, Sachem Head will not be liable to Nominee under this Agreement for any Expenses subsequently incurred by Nominee in


connection with the defense thereof other than reasonable costs of investigation and preparation therefor (including, without limitation, appearing as a witness and reasonable fees and expenses of legal counsel in connection therewith). If, in any action for which indemnity may be sought hereunder, Sachem Head shall not have timely assumed the defense thereof, or Nominee shall have been advised by his or her independent counsel in writing that it would constitute a conflict of interest for the same counsel to represent both Nominee and Sachem Head in such action, or if Nominee has been advised by independent counsel that Nominee has separate or additional defenses than those available to Sachem Head with regard to such action, Nominee shall have the right to employ his or her own counsel reasonably satisfactory to Sachem Head in such action, in which event Sachem Head shall pay directly or reimburse Nominee for any costs not paid directly for all reasonable out-of-pocket legal fees and expenses incurred by Nominee in connection with the defense thereof; provided, however, that Sachem Head shall be obligated to pay for only one firm to serve as counsel for all of Sachem Head’s nominees for election to the Board of Directors unless Nominee has been informed by independent counsel that there are conflicts of interest or additional defenses for Nominee relative to the other nominees. Nominee shall not settle any action without the prior written consent of Sachem Head, which consent shall not be unreasonably delayed or withheld. Sachem Head shall not settle any Claim in any manner that would impose any expense, penalty, obligation or limitation on Nominee, or would contain language (other than a recitation of any amounts to be paid in settlement) that could reasonably be viewed as an acknowledgment of wrongdoing on the part of Nominee, without Nominee’s prior written consent (which consent shall not be unreasonably delayed or withheld).
(c) Nominee’s right to indemnification pursuant to this Section 4 shall include the right of Nominee to be advanced by Sachem Head or a designee thereof any Expenses incurred in connection with any Indemnifiable Event as such expenses are incurred by Nominee; provided, however, that all amounts advanced in respect of such Expenses shall be promptly repaid to Sachem Head or a designee thereof by Nominee to the extent it shall ultimately be determined in a final judgment by a court of competent jurisdiction that Nominee is not entitled to be indemnified for or advanced such Expenses. The indemnification and reimbursement arrangements contemplated herein shall only take effect if Nominee is publicly named as a member of the Slate.
(d) Notwithstanding any other provision of this Agreement to the contrary, the indemnity and expense reimbursement obligations of Sachem Head provided by this Agreement will not apply to any event or occurrence (i) prior to the date hereof or (ii) relating to or directly or indirectly arising out of Nominee’s service as a director of the Company.
5. Publicity. From and after the date hereof until the date on which Nominee is elected or appointed to serve as a Director, Nominee shall coordinate with Sachem Head with respect to Nominee’s public disclosures regarding the Solicitation, including press releases, public announcements and statements or disclosures to the media concerning this Agreement, the Solicitation or any of the matters contemplated hereby, by using commercially reasonable efforts to notify Sachem Head with respect to any planned media engagements and, to the extent feasible, to coordinate with Sachem Head on the text of such disclosures or topics to be discussed in connection with such engagements.


6. Transactions in Securities of the Company. Nominee represents that Nominee does not, directly or indirectly, beneficially own any securities of the Company, or any interests or rights in respect of any securities of the Company (including, without limitation, any derivative securities), except as set forth on Exhibit A hereto. Until the earlier to occur of (i) Nominee’s election to the Board as a director of the Company or (ii) the termination of this Agreement, Nominee agrees that Nominee is prohibited from, directly or indirectly, purchasing, selling or otherwise acquiring or disposing of any securities of the Company, or any interests or rights in respect of any securities of the Company (including, without limitation, any derivative securities), without the prior written consent of Sachem Head.
7. No Agency. Each of Sachem Head and Nominee acknowledges that Nominee is not acting as an agent of Sachem Head or in a fiduciary capacity with respect to Sachem Head and that Nominee is not assuming any duties or obligations to Sachem Head other than those expressly set forth in this Agreement. Nothing contained herein shall be construed as creating, or be deemed to create, the relationship of employer and employee between the parties, nor any agency and nothing contained herein shall entitle Nominee to any compensation from Sachem Head. Each of Sachem Head and Nominee further acknowledges that, should Nominee be elected to the Board of Directors of the Company, Nominee will be acting as a director of the Company, on behalf of the Company and all of its stockholders, independent of and not controlled by Sachem Head, and all of Nominee’s activities and decisions as a director of the Company will be governed by applicable law and subject at all times to his or her fiduciary duties to the Company and its stockholders. Nothing in this Agreement is intended to or shall govern or restrict Nominee’s decisions or conduct as a Company director, which shall be based on Nominee’s independent business judgment. Other than as expressly set forth in Section 6, each of Sachem Head and Nominee further acknowledges that there is no agreement between or among them regarding the acquisition, voting, trading or holding of any shares of the Company.
8. Amendment; Waiver; Etc. No supplement, modification or amendment of this Agreement shall be binding unless executed in a writing signed by the parties hereto. No waiver of any provision of this Agreement shall be deemed or shall constitute a waiver of any other provisions hereof (whether or not similar) nor shall such waiver constitute a continuing waiver. The parties may not waive or vary any right hereunder except by an express written waiver or variation. Any failure to exercise or any delay in exercising any such rights, or any partial or defective exercise of any such rights, shall not operate as a waiver or variation of that or any other such right. The waiver by one party of any breach of this Agreement by another party shall not be deemed a waiver of any other prior or subsequent breach of this Agreement.
9. Subrogation. In the event of payment under this Agreement, Sachem Head shall be subrogated to the extent of such payment to all of the rights of recovery of Nominee, and Nominee shall execute all papers required and shall do everything that may be necessary to secure such rights, including the execution of such documents necessary to enable Sachem Head effectively to bring suit to enforce such rights.
10. No Duplication of Payments. Sachem Head shall not be liable under  this Agreement to make any payment in connection with a Claim made against Nominee to the extent Nominee has otherwise actually received payment (under any insurance policy, by-law or otherwise) of the amounts otherwise indemnifiable hereunder. In addition, Nominee shall be required to reimburse Sachem Head for any indemnification payments made to Nominee by


Sachem Head for any Losses to the extent that Nominee subsequently receives payment of such amounts from another source.
11. Notices. All notices, requests and other communications to any party hereunder shall be in writing (including telecopy or similar writing) and shall be given to such party,

if to Sachem Head, to:
Sachem Head Capital Management LP
250 West 55th Street, 34th Floor
New York, New York 10019
Attention:     Michael Adamski
Telephone: (212) 714-3314
Email:          michael@sachemhead.com

if to Nominee, to:
[•]
or such other address, email address or telecopy number as such party may hereafter specify for the purpose by notice to the other party hereby given in accordance with this Section 11. Each such notice, request or other communication shall be effective when delivered at the address specified in this Section 11.
12. Termination. This Agreement shall automatically terminate on the earlier to occur of (a) the completion of an unsuccessful Solicitation and (b) Nominee’s election or appointment to the Board of Directors; provided, that Sachem Head may terminate this Agreement at any time upon written notice to Nominee; provided, further, that Sachem Head’s obligations with respect to advancement, reimbursement and indemnification hereunder and Nominee’s obligations with respect to non-disclosure, advancement, reimbursement and indemnification hereunder shall each remain in full force and effect and survive the termination of this Agreement.
13. Nominee Acknowledgement. Nominee acknowledges that Sachem Head shall be under no obligation to propose Nominee for appointment or nominate Nominee for election and that Sachem Head may withdraw such nomination in its sole discretion. Nominee acknowledges that Sachem Head will rely upon information provided by Nominee for purposes of preparing submissions to the Company, proxy solicitation materials and other public disclosure.
14. Governing Law; Consent to Jurisdiction. This Agreement shall be governed by and construed in accordance with the laws of the State of New York, without giving effect to principles of conflicts of laws. Each party to this Agreement hereby irrevocably agrees that any legal action or proceeding arising out of or relating to this Agreement or any agreements


or transactions contemplated hereby shall be brought in the state courts of the State of New York located in New York County, or in the United States District Court for the Southern District of New York, and hereby expressly submits to the personal jurisdiction and venue of such courts for the purposes thereof and expressly waives any claim of improper venue and any claim that such courts are an inconvenient forum. Each party hereby irrevocably consents to the service of process of any of the aforementioned courts in any such suit, action or proceeding by the mailing of copies thereof by registered or certified mail, postage prepaid, to the address set forth or referred to in Section 11, such service to become effective ten days after such mailing.
15. Execution by Counterparts/Facsimile. This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original, but all of which together shall constitute one and the same instrument. This Agreement may also be executed by facsimile or PDF.
16. Expense Reimbursement. Sachem Head hereby agrees to reimburse Nominee for his or her reasonable, documented, out-of-pocket expenses incurred as a result of being a member of the Slate, including, without limitation, reimbursement for reasonable out-of- pocket travel expenses; provided, that Nominee hereby agrees that in the event Nominee reasonably determines that he or she needs to retain legal counsel to represent Nominee in connection with being a member of the Slate (other than in connection with a claim for indemnification, which is addressed in Section 4) he or she will employ counsel selected by Sachem Head and reasonably satisfactory to Nominee. Should Nominee be elected to the Board of Directors of the Company, other than as expressly set forth herein, Sachem Head will not be liable for any expenses or any other liabilities incurred by Nominee during the period following election to the Board of Directors of the Company.
17. Non-Disclosure. Nominee acknowledges and agrees to hold in strict confidence and will not use nor disclose to third parties information Nominee receives from Sachem Head or any of its agents or representatives or information developed by Nominee based upon such information Nominee receives from Sachem Head or any of its agents or representatives, except for (a) information which was public at the time of disclosure or becomes part of the public domain without disclosure by Nominee, (b) information which Nominee learns from a third party (other than Sachem Head or its agents or representatives) which does not have a legal, contractual or fiduciary obligation of confidentiality to Sachem Head or its agents or representatives, (c) following Nominee’s election as a director of the Company, information which is necessary for Nominee to disclose in order to comply with Nominee’s fiduciary duties under applicable law or (d) information which is required to be disclosed by applicable law; provided, that in the event of any required disclosure pursuant to this clause (d), Nominee hereby agrees to use commercially reasonable efforts to notify Sachem Head promptly so that Sachem Head may seek a protective order or other appropriate remedy or, in Sachem Head’s sole discretion, waive compliance with the terms of this Section 17; provided, further, that in the event that no such protective order or other remedy is obtained, or that Sachem Head waives compliance with the terms of this Section 17, Nominee further agrees to furnish only that portion of the confidential information which Nominee is advised by counsel is legally required and will cooperate with Sachem Head’s efforts, without incurring any monetary expense, to obtain assurance that confidential treatment will be accorded to the confidential information. Nominee further agrees not to (i) make any public communication relating to the Solicitation without the prior permission of Sachem Head or (ii) stand for election through nomination by the Company


or any other stockholder of the Company (other than Sachem Head), as director of the Company without the prior permission of Sachem Head. Nothing in this Section 17 shall constrain Nominee’s communications with his or her counsel, or prevent Nominee from disclosing information to his or her counsel. Sachem Head and the Nominee are joint participants in the Nominee’s engagement under this Agreement, and each party acknowledges and agrees that the parties share a common legal interest in connection with the Nominee’s engagement under this Agreement and any actual or threatened litigation, or governmental investigation, that may arise therefrom. Each party further acknowledges and agrees that it is the mutual desire, intention and understanding of the parties that the sharing of any information is not intended to, and shall not, waive or diminish in any way the confidentiality of such material or its continued protection under the attorney-client privilege, the attorney work product doctrine or any other applicable privilege or immunity, including the common interest privilege. Each of the parties further  agrees that information being provided by Sachem Head or its counsel is being provided solely for use in connection with the Nominee’s engagement under this Agreement and shall remain confidential in accordance with this Section 17 and shall be protected from disclosure to any third party by Sachem Head’s attorney-client privilege, the attorney work product  doctrine and/or any other applicable privileges and immunities, including the common interest privilege.
18. Entire Agreement. This Agreement constitutes the entire agreement among the parties hereto with respect to the matters covered hereby and supersedes all previous written, oral or implied understandings among them with respect to such matters.
19. Headings. The headings used herein are included for convenience of reference only and shall be ignored in the construction or interpretation of this Agreement.
20. Warranty of Authority. Each person executing this Agreement represents and warrants that he or she has full authority to sign this Agreement on behalf of the party for which he or she is acting and that the parties will thereby be fully bound by the terms of this Agreement. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors and permitted assigns.
21. Remedies. Nominee hereby acknowledges that money damages would be both difficult to calculate and speculative and an insufficient remedy for any breach of Nominee obligations in Sections 2, 3, 4, 5, 6 and/or 17 and that any such breach would cause Sachem Head irreparable harm. Accordingly, Nominee also agrees that in the event of any breach or threatened breach of Sections 2, 3, 4, 5, 6 and/or 17 Sachem Head, in addition to any other remedies at law or in equity it may have, shall be entitled to equitable relief, including injunctive relief and specific performance, without the requirement of posting a bond or other security or proof of actual damages.
[Signatures on following page]



IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

  SACHEM HEAD CAPITAL MANAGEMENT LP
 
       

By:
 
 
     
  Name: Michael D. Adamski
 
     
  Title:    General Counsel
 
       
       
       
       
       
  Name
[]
 


[Signature Page to Engagement and Indemnification Agreement]



Exhibit 99.3


ADVOCACY AGREEMENT
THIS ADVOCACY AGREEMENT, dated as of March 15, 2022 (the “Effective Date”), is by and between Sachem Head Capital Management LP (“Sachem Head”) and Corvex Management LP (“Corvex”) (each, a “Party” and, collectively, the “Parties”).
WHEREAS, on March 7, 2022, the Parties agreed to coordinate their efforts with respect to Anaplan, Inc. (the “Company”);
WHEREAS, the Parties, including their respective controlled affiliates and any investment funds, managed accounts or other investment vehicles managed or advised by the Parties (collectively, each Party’s “Covered Entities”), wish to memorialize their agreement to coordinate their efforts with respect to the Company and the Parties’ ownership of shares of the Company’s common stock or other interests in respect of such shares (including any derivative or swap interests) (“Company Securities”).
NOW, THEREFORE, in consideration of the covenants and agreements set forth in this agreement, and for other good and valuable consideration the receipt and sufficiency of which are acknowledged, and intending to be legally bound, the Parties agree as follows:
1. Purchase and Sale of Securities. Except as set forth below, nothing contained in this agreement shall restrict the trading activities of either Party or its Covered Entities. In the event the Company adopts a shareholder rights plan, each Party and its Covered Entities shall use their reasonable best efforts not to directly or indirectly acquire ownership of additional Company Securities unless otherwise mutually agreed by the Parties.
2. Coordinated Activities. From and after the Effective Date, the Parties intend to coordinate their activities with each other as relates to the Company and, in furtherance thereof, the Parties shall use their reasonable best efforts to consult with each other in connection with the following matters: (i) the manner, form, content and timing of any communications with the Company or any of its other stockholders, whether written or oral, including (a) the selection of nominees to serve as directors of the Company, (b) making, revising, or withdrawing any proposals to other stockholders of the Company or to the Company, and (c) the conduct of any proxy contest, consent solicitation or similar actions in respect of the Company; (ii) the manner, form, content and timing of any regulatory or public disclosures (including the filing of a Schedule 13D (or any amendment thereof)), public statements or other communications relating to the Company, the Company Securities, this agreement or the activities contemplated by this agreement (except that, if such disclosure, statement or communication is required by law, regulation or fund documentation applicable to a Party, such Party may make such required disclosure, statement or other communication without the agreement of the other Party, provided that such Party has delivered prior notice thereof to the other Party), (iii) any significant decisions in connection with the Company or the activities contemplated by this agreement, (iv) admission of any additional members to any group (within the meaning of Section 13 of the Securities Exchange Act of 1934, as amended) with respect to the Company Securities that includes either Party, whether formed by this agreement or otherwise, and (v) entering into any confidentiality, extension, settlement,


cooperation, standstill or other similar agreement with the Company. The Parties retain full discretion with respect to voting of their respective Company Securities.
3. Expenses. Each Party will bear its own expenses in connection with this agreement, except (i) that the Parties agree to share equally (and promptly reimburse the other Party for) all fees and expenses in respect of any mutually agreed advisors that are engaged by or on behalf of the Parties, and (ii) as otherwise mutually agreed in writing by the Parties.
4. No Liability. Notwithstanding anything else contained in this agreement, neither Party nor any of its Covered Entities shall have liability of any kind whatsoever to the other Party or any of the other Party’s Covered Entities, including in connection with the execution of any trade in Company Securities, except in the case of a breach of this agreement, a violation of applicable law or regulations, fraud, willful misconduct or gross negligence by the first Party.
5. Regulatory Reporting. Each Party shall be responsible for the accuracy and completeness of its own disclosure required to be made under applicable law or regulation with any regulatory authority or stock exchange, and shall not be responsible for the accuracy or completeness of the information concerning the other Party. The Parties shall use reasonable best efforts to promptly share information with each other regarding their trading in Company Securities in order to facilitate timely regulatory or public disclosures.  The Parties shall use their reasonable best efforts to cooperate in connection with any other regulatory filing that may be required to be made in connection with the matters contemplated by this agreement.
6. Termination. This agreement may be terminated at any time by either Party following written notice to the other Party. In the event of termination, the Parties shall cooperate to take such actions as may be necessary or required publicly to disclose such termination and/or the consequences thereof.
7. Relationship of the Parties. Nothing in this agreement shall be construed as creating (including, without limitation, for U.S. income tax purposes) any agency relationship, nor shall either Party, except as expressly set forth in this agreement, (i) have the right, power or authority to create any obligation or duty, express or implied, on behalf of the other Party or (ii) have any fiduciary or other duties to the other Party.
8. Notices. All notices permitted or required hereunder shall be in writing and delivered personally or sent by overnight express mail or courier or sent by electronic mail to the other Party at the address below (or at such other address as a Party shall designate in writing to the other Party in the manner specified herein) and shall be effective at the earlier of the date received or, if by electronic mail, upon confirmation of receipt.
If intended for Sachem Head:

Sachem Head Capital Management LP
250 West 55th St., Floor 34
New York, New York 10019
Attention: Michael D. Adamski
Email: Michael@sachemhead.com
-2-


If intended for Corvex:

Corvex Management LP
667 Madison Avenue
New York, NY 10065
Attention: Patrick J. Dooley
Email: pdooley@corvexcap.com
9. Privilege; Joint Defense. Each Party understands and agrees that the Parties have a commonality of interest with respect to matters that are the subject of this agreement and it is the desire, intention and mutual understanding of the Parties that the sharing of materials or any communications between the Parties shall remain confidential and is not intended to, and shall not, waive or diminish in any way each Party’s protection under the attorney-client privilege, work product doctrine or other applicable privilege. All information that is entitled to protection under the attorney-client privilege, work product doctrine or other applicable privilege shall remain entitled to such protection under these privileges, this agreement, and under the joint defense doctrine.
10. Miscellaneous. This agreement (i) shall be governed by and construed in accordance with the laws of the State of New York, (ii) may not be assigned, amended, waived or modified except by a writing signed by each Party, (iii) may be executed in counterparts, each of which shall be deemed an original but both of which together shall constitute one and the same instrument, (iv) is solely for the benefit of the Parties hereto and no other person shall have any rights hereunder, and (v) constitutes the entire understanding between the Parties with respect to the subject matter hereof.
[Signature Page Next]
-3-

IN WITNESS WHEREOF, the Parties have caused this agreement to be executed as of the Effective Date.
  SACHEM HEAD CAPITAL MANAGEMENT LP  
       
    By: 
Uncas GP LLC, its General Partner
 
       

 By:
/s/  Scott D. Ferguson
 
    Name:  Scott D. Ferguson
 
    Title:    Managing Member  
       

  CORVEX MANAGEMENT LP  
       

By:
/s/  Keith A. Meister
 
    Name:  Keith A. Meister
 
    Title:    Managing Partner  
       
[Signature Page to Advocacy Agreement]






Exhibit 99.4

TRADING DATA

The following table sets forth all transactions in the Common Stock of the Issuer effected in the last sixty days by the Sachem Head Funds. Except as otherwise noted below, all such transactions were purchases or sales of shares of Common Stock effected in the open market, and the table excludes commissions paid in per share prices.

Entity
Trade Date
Buy/Sell
No. of Shares/
Quantity
Unit Cost/
Proceeds
Security
Expiration Date
Sachem Head LP
02/01/2022
Buy
4,312
48.2800
OTC physically settled total return swap*
1/30/2025
Sachem Head LP
02/09/2022
Buy
100
46.6550
Common stock
N/A
Sachem Head LP
3/01/2022
Sell
2,674
47.3700
OTC physically settled total return swap*
1/30/2025
Sachem Head Master LP
02/01/2022
Sell
4,312
48.2800
OTC physically settled total return swap*
12/6/2024
Sachem Head Master LP
02/09/2022
Buy
100
46.6550
Common stock
N/A
Sachem Head Master LP
3/01/2022
Buy
2,674
47.3700
OTC physically settled total return swap*
2/27/2025
SH Stony Creek Master Ltd.
02/03/2022
Buy
60,000
44.8890
OTC physically settled total return swap
2/5/2025
SH Sagamore Master IX Ltd.
01/18/2022
Buy
234,727
45.5130
Common stock
N/A
SH Sagamore Master IX Ltd.
01/19/2022
Buy
41,973
46.6120
Common stock
N/A
SH Sagamore Master IX Ltd.
01/25/2022
Buy
650,000
43.2330
OTC physically settled total return swap
1/27/2025
SH Sagamore Master IX Ltd.
01/26/2022
Buy
300,000
43.5190
OTC physically settled total return swap
1/27/2025

* Trade represents a rebalancing transaction.